Sâmia Joca - Search Results

Year	Number of Results
2002	3
2003	2
2006	4
2007	2
2008	2
2009	2
2010	3
2011	5
2012	2
2013	4
2014	3
2015	11
2016	4
2017	8
2018	12
2019	15
2020	8
2021	10
2022	11
2023	8
2024	4

1

Psychiatric and neuropsychiatric sequelae of COVID-19 - A systematic review.

Schou TM, Joca S, Wegener G, Bay-Richter C. Schou TM, et al. Among authors: joca s. Brain Behav Immun. 2021 Oct;97:328-348. doi: 10.1016/j.bbi.2021.07.018. Epub 2021 Jul 30. Brain Behav Immun. 2021. PMID: 34339806 Free PMC article. Review.

2

Nitric oxide signalling and antidepressant action revisited.

Joca SRL, Sartim AG, Roncalho AL, Diniz CFA, Wegener G. Joca SRL, et al. Cell Tissue Res. 2019 Jul;377(1):45-58. doi: 10.1007/s00441-018-02987-4. Epub 2019 Jan 16. Cell Tissue Res. 2019. PMID: 30649612 Review.

3

Epigenetic Basis of Neuronal and Synaptic Plasticity.

Karpova NN, Sales AJ, Joca SR. Karpova NN, et al. Among authors: joca sr. Curr Top Med Chem. 2017;17(7):771-793. doi: 10.2174/1568026616666160414124628. Curr Top Med Chem. 2017. PMID: 27086781 Review.

4

P2X7 Receptor Signaling in Stress and Depression.

Ribeiro DE, Roncalho AL, Glaser T, Ulrich H, Wegener G, Joca S. Ribeiro DE, et al. Among authors: joca s. Int J Mol Sci. 2019 Jun 6;20(11):2778. doi: 10.3390/ijms20112778. Int J Mol Sci. 2019. PMID: 31174279 Free PMC article. Review.

5

Atypical Neurotransmitters and the Neurobiology of Depression.

Joca SR, Moreira FA, Wegener G. Joca SR, et al. CNS Neurol Disord Drug Targets. 2015;14(8):1001-11. doi: 10.2174/1871527314666150909114804. CNS Neurol Disord Drug Targets. 2015. PMID: 26350337 Review.

6

Targeting 2-arachidonoylglycerol signalling in the neurobiology and treatment of depression.

Silveira KM, Wegener G, Joca SRL. Silveira KM, et al. Among authors: joca srl. Basic Clin Pharmacol Toxicol. 2021 Jul;129(1):3-14. doi: 10.1111/bcpt.13595. Epub 2021 May 17. Basic Clin Pharmacol Toxicol. 2021. PMID: 33905617 Free article. Review.

7

The Cannabis-Induced Epigenetic Regulation of Genes Associated with Major Depressive Disorder.

Mohammad GS, Joca S, Starnawska A. Mohammad GS, et al. Among authors: joca s. Genes (Basel). 2022 Aug 12;13(8):1435. doi: 10.3390/genes13081435. Genes (Basel). 2022. PMID: 36011346 Free PMC article. Review.

8

Tiny in size, big in impact: Extracellular vesicles as modulators of mood, anxiety and neurodevelopmental disorders.

Duarte-Silva E, Oriá AC, Mendonça IP, de Melo MG, Paiva IHR, Maes M, Joca SRL, Peixoto CA. Duarte-Silva E, et al. Among authors: joca srl. Neurosci Biobehav Rev. 2022 Apr;135:104582. doi: 10.1016/j.neubiorev.2022.104582. Epub 2022 Feb 16. Neurosci Biobehav Rev. 2022. PMID: 35182538 Review.

9

The NLRP3 Inflammasome in Stress Response: Another Target for the Promiscuous Cannabidiol.

Hartmann A, Vila-Verde C, Guimarães FS, Joca SR, Lisboa SF. Hartmann A, et al. Among authors: joca sr. Curr Neuropharmacol. 2023;21(2):284-308. doi: 10.2174/1570159X20666220411101217. Curr Neuropharmacol. 2023. PMID: 35410608 Free PMC article. Review.

10

Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms.

Silote GP, Sartim A, Sales A, Eskelund A, Guimarães FS, Wegener G, Joca S. Silote GP, et al. Among authors: joca s. J Chem Neuroanat. 2019 Jul;98:104-116. doi: 10.1016/j.jchemneu.2019.04.006. Epub 2019 Apr 27. J Chem Neuroanat. 2019. PMID: 31039391 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

102 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Results by year